site-logo
  • LiquidHALLMARK®
  • Multi-Cancer Screening
  • Resources
    • Publications
    • News & Events
  • Patients
  • Company
    • About Us
    • News & Events
    • Careers
    • Contact Us
  • Portal Login

News & Update: News

Interim Results from LIQUIK Prospective Study Released at WCLC 2023

Interim Results from LIQUIK Prospective Study Released at WCLC 2023

Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

Lucence secures US Medicare approval for its cancer tests

Lucence secures US Medicare approval for its cancer tests

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

Posts navigation

Older posts
Up arrow Back to top
Footer logo
Reach Us
3520 W Bayshore Road, Palo Alto, CA 94303 [email protected] (888) 582 3623
Subscribe for Updates

    Follow Us
    • facebook facebook-white
    • linkedin linkedin-white
    • twitter twitter-white

    © 2023 Lucence Health Inc. All rights reserved. All logos and trademarks are the property of Lucence or their respective owners.

    LiquidHALLMARK® | AmpliMark™ | Publications| Careers | About | Privacy

    Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO

    >